Cargando…
PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis
Targeted therapies such as venetoclax (VEN) (Bcl-2 inhibitor) have revolutionized the treatment of chronic lymphocytic leukemia (CLL). We previously reported that persister CLL cells in treated patients overexpress multiple antiapoptotic proteins and display resistance to proapoptotic agents. Here,...
Autores principales: | Jayappa, Kallesh D., Tran, Brian, Gordon, Vicki L., Morris, Christopher, Saha, Shekhar, Farrington, Caroline C., O’Connor, Caitlin M., Zawacki, Kaitlin P., Isaac, Krista M., Kester, Mark, Bender, Timothy P., Williams, Michael E., Portell, Craig A., Weber, Michael J., Narla, Goutham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313372/ https://www.ncbi.nlm.nih.gov/pubmed/37166997 http://dx.doi.org/10.1172/JCI155938 |
Ejemplares similares
-
Sirt3 targets mPTP and prevents aging in the heart
por: Sadoshima, Junichi
Publicado: (2011) -
Effect of the CRAC Peptide, VLNYYVW, on mPTP Opening in Rat Brain and Liver Mitochondria
por: Azarashvili, Tamara, et al.
Publicado: (2016) -
Extracellular acidification induces ROS- and mPTP-mediated death in HEK293 cells
por: Teixeira, José, et al.
Publicado: (2017) -
Identification of Phosphorylated Calpain 3 in Rat Brain Mitochondria under mPTP Opening
por: Baburuna, Yulia, et al.
Publicado: (2021) -
Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight
por: Waseem, Mohammad, et al.
Publicado: (2023)